Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jun 14, 2023

BUY
$31.15 - $33.39 $723,521 - $775,549
23,227 New
23,227 $771,000
Q3 2022

Jun 14, 2023

BUY
$30.9 - $33.55 $717,714 - $779,265
23,227 New
23,227 $732,000
Q2 2022

Jun 20, 2023

BUY
$23.75 - $31.69 $551,641 - $736,063
23,227 New
23,227 $706,000
Q1 2022

May 10, 2024

BUY
$19.97 - $26.94 $463,843 - $625,735
23,227 New
23,227 $602,000
Q1 2022

Jun 20, 2023

BUY
$19.97 - $26.94 $463,843 - $625,735
23,227 New
23,227 $602,000
Q1 2022

Mar 22, 2023

BUY
$19.97 - $26.94 $170,064 - $229,421
8,516 Added 57.89%
23,227 $602,000
Q1 2022

May 12, 2022

BUY
$19.97 - $26.94 $170,064 - $229,421
8,516 Added 57.89%
23,227 $603,000
Q4 2021

Jun 21, 2023

BUY
$17.46 - $21.61 $256,854 - $317,904
14,711 New
14,711 $300,000
Q3 2021

May 17, 2024

SELL
$17.35 - $22.5 $73,130 - $94,837
-4,215 Reduced 22.27%
14,711 $283,000
Q3 2021

Jun 21, 2023

BUY
$17.35 - $22.5 $255,235 - $330,997
14,711 New
14,711 $283,000
Q3 2021

Mar 22, 2023

SELL
$17.35 - $22.5 $73,130 - $94,837
-4,215 Reduced 22.27%
14,711 $283,000
Q3 2021

Nov 15, 2021

SELL
$17.35 - $22.5 $73,130 - $94,837
-4,215 Reduced 22.27%
14,711 $283,000
Q2 2021

Jun 21, 2023

BUY
$18.01 - $28.32 $340,857 - $535,984
18,926 New
18,926 $419,000
Q1 2021

May 17, 2024

BUY
$19.76 - $29.89 $373,977 - $565,698
18,926 New
18,926 $496,000
Q1 2021

Jun 26, 2023

BUY
$19.76 - $29.89 $373,977 - $565,698
18,926 New
18,926 $497 Million
Q4 2020

Jun 22, 2023

BUY
$15.73 - $21.66 $297,705 - $409,937
18,926 New
18,926 $353,000
Q3 2020

May 24, 2024

SELL
$13.54 - $26.41 $49,096 - $95,762
-3,626 Reduced 16.08%
18,926 $321 Million
Q3 2020

Jun 26, 2023

BUY
$13.54 - $26.41 $256,258 - $499,835
18,926 New
18,926 $321,000
Q3 2020

Mar 22, 2023

SELL
$13.54 - $26.41 $49,096 - $95,762
-3,626 Reduced 16.08%
18,926 $321,000
Q3 2020

Nov 13, 2020

SELL
$13.54 - $26.41 $49,096 - $95,762
-3,626 Reduced 16.08%
18,926 $321,000
Q2 2020

May 24, 2024

BUY
$7.84 - $23.29 $176,807 - $525,236
22,552 New
22,552 $525 Million
Q2 2020

Jun 26, 2023

BUY
$7.84 - $23.29 $176,807 - $525,236
22,552 New
22,552 $525,000
Q1 2020

Jul 12, 2023

BUY
$5.57 - $11.5 $125,614 - $259,348
22,552 New
22,552 $189,000
Q4 2019

Jul 12, 2023

BUY
$7.9 - $10.14 $178,160 - $228,677
22,552 New
22,552 $220,000
Q3 2019

Jul 12, 2023

BUY
$9.17 - $12.01 $206,801 - $270,849
22,552 New
22,552 $214,000
Q2 2019

Jul 12, 2023

BUY
$10.88 - $17.6 $245,365 - $396,915
22,552 New
22,552 $267,000
Q1 2019

Jul 13, 2023

BUY
$15.51 - $17.61 $349,781 - $397,140
22,552 New
22,552 $397,000
Q4 2018

Jul 13, 2023

BUY
$14.52 - $19.72 $327,455 - $444,725
22,552 New
22,552 $391,000
Q4 2018

Mar 22, 2023

SELL
$14.52 - $19.72 $166,689 - $226,385
-11,480 Reduced 33.73%
22,552 $391,000
Q4 2018

Feb 14, 2019

SELL
$14.52 - $19.72 $166,689 - $226,385
-11,480 Reduced 33.73%
22,552 $392,000
Q3 2018

Jul 13, 2023

BUY
$14.85 - $16.35 $334,897 - $368,725
22,552 New
22,552 $336,000
Q3 2018

Mar 22, 2023

BUY
$14.85 - $16.35 $160,454 - $176,661
10,805 Added 46.52%
34,032 $507,000
Q3 2018

Nov 14, 2018

BUY
$14.85 - $16.35 $170,478 - $187,698
11,480 Added 50.9%
34,032 $507,000
Q4 2017

Feb 15, 2018

BUY
$13.55 - $15.8 $305,579 - $356,321
22,552
22,552 $316,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.